JAZZ Insider Trading

Jazz Pharmaceuticals plc (JAZZ) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $13.22B, listed on NASDAQ, employing roughly 2,890 people, carrying a beta of 0.32 to the broader market. Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. Led by Renee D. Gala, public since 2007-06-01.

In the last 12 months, Jazz Pharmaceuticals plc insiders made 0 buy transactions and 58 sale transactions.

DateNameTypeSharesPriceValue
Oct 7, 2026GALA RENEE DS-Sale2,000$236.40$472.8K
Oct 5, 2026COZADD BRUCE CS-Sale6,000$230.33$1.4M
Sep 14, 2026Patil Neena MS-Sale1,200$240.94$289.1K
Sep 10, 2026GALA RENEE DF-InKind1,967$246.81$485.5K
Sep 10, 2026GALA RENEE DS-Sale2,000$243.03$486.1K
Sep 10, 2026Henderson Mary ElizabethF-InKind1,412$243.03$343.2K
Sep 10, 2026Henderson Mary ElizabethF-InKind15$241.20$3.6K
Sep 2, 2026Henderson Mary ElizabethF-InKind2,076$241.39$501.1K
Sep 2, 2026Henderson Mary ElizabethF-InKind16$244.64$3.9K
Sep 2, 2026Smith Mark DouglasF-InKind14$244.64$3.4K

JAZZ Insider Activity by Quarter

Reported Form 4 and Form 5 lines under JAZZ's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jun 10, 2022, and a quarter counts only when every filing for it was read.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A2$1.9M0
Q3 20260N/A11$24.4M45
Q2 20260N/A10$6.0M12
Q1 20260N/A19$14.2M38
Q4 20250N/A18$22.7M14
Q3 20250N/A5$992.5K25
Q2 20254$10.0M5$470.9K0
Q1 20250N/A10$3.5M39
Q4 20240N/A4$816.3K1

JAZZ Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 643 institutions reported holding 64,391,362 JAZZ shares, valued at $15.49B as reported, 108.8% of its market cap (market cap of Jun 26, 2026). That is +68 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 123 opened a position, 51 closed one, 240 added and 188 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
BlackRock, Inc.5,968,603$1.44B+376,903
FMR LLC4,609,326$1.11B+2,333,564
VANGUARD PORTFOLIO MANAGEMENT LLC3,036,213$731.6M+52,971
VANGUARD CAPITAL MANAGEMENT LLC2,729,650$657.8M+81,317
Capital World Investors2,697,610$650.0M+24,234
LSV ASSET MANAGEMENT2,275,145$548.2M-111,695
FRANKLIN RESOURCES INC2,040,250$491.6M+81,310
STATE STREET CORP1,999,816$481.9M+108,170
DIMENSIONAL FUND ADVISORS LP1,713,592$412.9M-181,623
FULLER & THALER ASSET MANAGEMENT, INC.1,638,544$394.8M-37,598

By Quarter

QuarterInstitutionsSharesValue
Q2 202664364,391,362$15.49B
Q1 202657565,046,728$12.28B
Q4 202557463,405,970$10.77B
Q3 202550162,529,450$8.24B
Q2 202550062,133,942$6.59B
Q1 202554458,923,124$7.31B
Q4 202450559,093,706$7.27B
Q3 202447159,180,040$6.59B
Q2 202444959,726,951$6.38B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding JAZZ

FundWeight of JAZZShares (as reported)Value (as reported)Source updated
VTI Vanguard Morningstar Total Stock Market ETF0.02%1,892,505$474.4MOct 7, 2026
VB Vanguard Morningstar Small-Cap ETF0.18%1,371,151$343.7MOct 7, 2026
VBR Vanguard Morningstar Small-Cap Value ETF0.32%870,973$218.3MOct 7, 2026
VXF Vanguard Extended Market ETF0.19%728,698$182.7MOct 7, 2026
XMMO Invesco S&P MidCap Momentum ETF2.28%699,444$161.7MOct 8, 2026
VFLO VictoryShares Free Cash Flow ETF1.35%660,771$152.8MOct 8, 2026
MDY State Street SPDR S&P MIDCAP 400 ETF Trust0.44%484,237$113.7MOct 8, 2026
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.44%347,288$81.4MOct 8, 2026
DFAT Dimensional - US Targeted Value ETF0.25%332,467$76.9MOct 8, 2026
AVLV Avantis U.S. Large Cap Value ETF0.27%249,314$57.6MOct 8, 2026
IWR iShares Russell Mid-Cap ETF0.10%247,041$57.1MOct 8, 2026
DFAC Dimensional - US Core Equity 2 ETF0.06%237,965$55.1MOct 8, 2026
IHE iShares U.S. Pharmaceuticals ETF3.39%224,497$51.9MOct 8, 2026
SCHM Schwab U.S. Mid-Cap ETF0.31%195,219$45.2MOct 7, 2026
VHT Vanguard Health Care ETF0.20%177,319$44.5MOct 7, 2026

From each fund's latest holdings file on record that shows JAZZ's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as JAZZ's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for JAZZ reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is JAZZ's share of that fund.

JAZZ Congress Trades

Members of Congress and their households disclosed 3 transactions in JAZZ on file (1 purchases, 2 sales) by 2 members, the latest trade on Jul 12, 2023.

MemberChamberTypeAmountTradedDisclosed
Daniel S. Goldman (D-NY-10)HouseSale (Full)$15,001 - $50,000Jul 12, 2023Aug 13, 2023
Ro Khanna (D-CA-17)HouseSale$1,001 - $15,000May 19, 2023Jun 12, 2023
Daniel S. Goldman (D-NY-10)HousePurchase$15,001 - $50,000Mar 6, 2023Apr 17, 2023

From the periodic transaction reports members of the Senate and the House file under the STOCK Act, within 45 days of a trade (some file later); amounts are the ranges the reports give (a few give an exact amount), and a transaction a later report lists again is counted once. On file: House reports disclosed from Apr 10, 2023 through Oct 13, 2026; Senate reports disclosed from Jan 30, 2014 through Oct 7, 2026. The party is the member's on the trade date. A trade is listed under the company that traded under its ticker on the trade date (dated from Feb 1, 2021, unless the filing describes another company of ours; before that, only when the filing's description of the security is the company's name).

How to Read JAZZ Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 58 sales versus 0 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked JAZZ insider trading questions

How active are JAZZ insiders right now?
Over the trailing twelve months, Jazz Pharmaceuticals plc (JAZZ) insiders made 0 buy transactions and 58 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (58 sales vs 0 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are JAZZ insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do JAZZ insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.